Zhejiang Cheng Yi Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -6.64% vs 19.35% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -15.69% vs 72.31% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "201.00",
          "val2": "215.30",
          "chgp": "-6.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "43.80",
          "val2": "55.50",
          "chgp": "-21.08%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.30",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "44.60",
          "val2": "52.90",
          "chgp": "-15.69%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "218.10%",
          "val2": "148.10%",
          "chgp": "7.00%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 13.63% vs 6.15% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -1.64% vs 23.95% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "803.90",
          "val2": "707.50",
          "chgp": "13.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "268.10",
          "val2": "220.20",
          "chgp": "21.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.90",
          "val2": "11.20",
          "chgp": "-65.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.30",
          "val2": "-20.70",
          "chgp": "79.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "197.50",
          "val2": "200.80",
          "chgp": "-1.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "215.60%",
          "val2": "174.50%",
          "chgp": "4.11%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ

Mar'26

Dec'25

Change(%)

Net Sales

201.00

215.30

-6.64%

Operating Profit (PBDIT) excl Other Income

43.80

55.50

-21.08%

Interest

0.20

0.30

-33.33%

Exceptional Items

0.00

0.00

Consolidate Net Profit

44.60

52.90

-15.69%

Operating Profit Margin (Excl OI)

218.10%

148.10%

7.00%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Mar 2026 is -6.64% vs 19.35% in Dec 2025

Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -15.69% vs 72.31% in Dec 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

803.90

707.50

13.63%

Operating Profit (PBDIT) excl Other Income

268.10

220.20

21.75%

Interest

3.90

11.20

-65.18%

Exceptional Items

-4.30

-20.70

79.23%

Consolidate Net Profit

197.50

200.80

-1.64%

Operating Profit Margin (Excl OI)

215.60%

174.50%

4.11%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 13.63% vs 6.15% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -1.64% vs 23.95% in Dec 2024

All Annual Results